Bone mineral density in patients of Graves disease pre- & posttreatment in a predominantly vitamin D deficient population

Indian Journal of Medical Research

Volumn 135, Issue 1, 2012, Pages 36-41

  Jyotsna, Viveka P ^a   Sahoo, Abhay ^a   Ksh, Singh Achouba ^a   Sreenivass, V ^a   Gupta, Nandita ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bone mineral density; Graves'disease; Hyperthyroidism; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; CARBIMAZOLE; CREATININE; PHOSPHATE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY MASS; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DISEASE ASSOCIATION; EUTHYROIDISM; FEMALE; FOLLOW UP; FOREARM; GRAVES DISEASE; HIP; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PHOSPHATE URINE LEVEL; SPINE; SUNLIGHT; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; ALKALINE PHOSPHATASE; BONE DENSITY; CALCIUM; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; MALE; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84857857549     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: 10.4103/0971-5916.93422     Document Type: Article

References (24)

1. Tsai KS, Lai SM, Huang KM, Chieng PU, Su CT, Chen FW. Decreased bone mineral density in patients with prolonged thyrotoxicosis before and after treatment. J Formos Med Assoc 1991; 90: 250-5.
2. Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 1990; 19: 35-63.
3. Wejda B, Hintze G, Katschinski B, Olbricht T, Benker G. Hip fractures and the thyroid: a case-control study. J Intern Med 1995; 237: 241-7.
4. Stall GM, Harris S, Sokoll LJ, Dawson-Hughes B. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med 1990; 113: 265-9.
5. Bayley TA, Harrison JE, McNeil1 KG, Mernagh JR. Effect of thyrotoxicosis and its treatment on bone mineral and muscle mass. J Clin Endocrinol Metab 1980; 50: 916-22.
6. Toh SH, Claunch BC, Brown PH. Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med 1985; 145: 883-6.
7. Mosekilde L, Lund B, Sorensen OH, Christensen MS, Melsen F. Serum-25-hydroxy cholecalciferol in hyperthyroidism. Lancet 1977; 1: 806-7.
8. Yamasita H, Noguchi S, Takatsu K, Takatsu K, Koike E, Murakami T, et al. High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease. Endocrine J 2001; 48: 63-9.
9. Nagasaka S, Sugimoto H, Nakamura T, Kusaka I, Fujisawa G, Sakuma N, et al. Anti-thyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis. Clin Endocrinol (Oxf) 1997; 47: 215-21.
10. Mosekilde L, Christensen M.S., Melsen F, Sorensen NS. Effect of antithyroid treatment on calcium-phosphorous metabolism in hyperthyroidism: chemical quantities in serum and urine. Acta Endocrinol (Copenh) 1978; 87: 743-50.
11. Rosen CJ, Adler RA. Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab 1992; 75: 1531-4.
12. Jodar E, Munoz-Torres M, Escobar-Jimenez F, Quesada M, Luna JD, Olea N. Anti-resorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism. J Clin Endocrinol Metab 1997; 82: 1989-94.
13. Mora S, Weber G, Marenzi K, Signorini E, Rovelli R, Proverbio MC, et al. Longitudinal changes of bone density & bone resorption in hyperthyroid girls during treatment. J Bone Miner Res 1999; 14: 1971-7.
14. Oikawa M, Kushida K, Takahashi M, Ohishi T, Hoshino H, Suzuki M, et al. Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time. Clin Endocrinol (Oxf) 1999; 50: 171-6.
15. Toh SH, Claunch BC, Brown PH. Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med 1985; 145: 883-6.
16. Harinarayan CV, Joshi SR. Vitamin D status in India - its implications and remedial measures. J Assoc Physicians India 2009; 57: 40-8.
17. Goswami R, Gupta N, Goswami D, Marwaha RK, Tandon N, Kochupillai N. Prevalence and significance of low 25- hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr 2000; 72: 472-5.
18. Udayakumar N, Chandrasekaran M, Rasheed MH, Suresh RV, Sivaprakash S. Evaluation of bone mineral density in thyrotoxicosis. Singapore Med J 2006; 47: 947-50.
19. Baxter JD, Bondy PK. Hypercalcemia of thyrotoxicosis. Ann Intern Med 1966; 65: 429-42.
20. Richards AJ. Hypercalcaemia in thyrotoxicosis with and without hyperparathyroidism. Postgrad Med J 1970; 46: 440-6.
21. Cooper DS, Kaplan MM, Ridgway EC, Maloof F, Daniels GH. Alkaline phosphatase isoenzyme patterns in hyperthyroidism. Ann Intern Med 1979; 90: 164-8.
22. Siddiqi A, Burrin JM, Noonan K, James I, Wood DF, Price CP, et al. A longitudinal study of markers of bone turnover in Grave's disease & their value in predicting bone mineral density. J Clin Endocrinol Metab 1997; 82: 753-9.
23. El Maghraoui A, Guerboub AA, Mounach A, Ghozlani I, Nouijai I, Ghazi M, et al. Body mass index & gynecological factors as determinants of bone mass in healthy Moroccan women. Maturitas 2007; 56: 375-82.
24. Fraser SA, Anderson JB, Smith AD, Wilson GM. Osteoporosis and fractures following thyrotoxicosis. Lancet 1971; 1: 981-3.